the latest

Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors

Sensorium Therapeutics Appoints Jeffrey M. Brown as Chief Scientific Officer

Boston Business Journal: MGH scientists get $30M to make drugs using natural psychoactives

BioWorld: Sensorium raises $30M in series A round to probe plants, fungi for psychoactive natural products

Endpoints News: Mining from plants and fungi, CNS startup takes leap into psychoactive drugs — complete with $30M to kick things off

BioSpace: Sensorium Scores $30M to Change Risk-Value Proposition in CNS Drug Discovery

Sensorium Therapeutics Closes $30 Million Series A to Transform Mental Health Treatment with Nature-Inspired Psychoactive Medicines